| Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 39.93B | 36.60B | 30.67B | 30.07B | 28.64B |
| Gross Profit | 9.63B | 8.30B | 6.95B | 7.24B | 6.56B |
| EBITDA | 3.22B | 2.54B | 1.62B | 2.12B | 1.82B |
| Net Income | 1.81B | 1.52B | 803.18M | 1.12B | 931.26M |
Balance Sheet | |||||
| Total Assets | 30.93B | 29.10B | 26.13B | 25.88B | 26.24B |
| Cash, Cash Equivalents and Short-Term Investments | 3.00B | 5.81B | 2.20B | 4.72B | 3.49B |
| Total Debt | 1.86B | 884.68M | 959.69M | 1.24B | 1.73B |
| Total Liabilities | 10.49B | 9.99B | 8.51B | 8.93B | 9.86B |
| Stockholders Equity | 20.45B | 19.11B | 17.63B | 16.95B | 16.38B |
Cash Flow | |||||
| Free Cash Flow | -1.40B | 4.05B | -1.48B | 2.35B | 907.59M |
| Operating Cash Flow | 544.47M | 4.33B | -1.44B | 2.41B | 1.04B |
| Investing Cash Flow | -3.93B | -454.46M | -307.92M | -472.56M | -458.22M |
| Financing Cash Flow | 574.12M | -266.50M | -780.77M | -710.32M | -698.41M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥17.21B | 5.97 | ― | 4.20% | ― | ― | |
74 Outperform | ¥13.44B | 10.35 | ― | 4.14% | 10.34% | 31.01% | |
70 Outperform | ¥15.96B | 176.80 | ― | 2.66% | 8.62% | 11.21% | |
68 Neutral | ¥1.68B | 4.03 | ― | 2.23% | -9.48% | -66.01% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
58 Neutral | ¥27.00B | 23.25 | ― | 2.64% | 0.20% | -26.61% | |
54 Neutral | ¥4.28B | -27.75 | ― | 3.25% | -1.20% | -1136.47% |